4-Chlorothieno[3,2-d]pyrimidine: Handling & Synthesis Protocol

4-chlorothieno[3,2-d]pyrimidine is a bicyclic heteroaromatic intermediate bearing an electrophilic chloride at the 4-position, making it a versatile building block for the synthesis of thienopyrimidine-based kinase inhibitors and other bioactive small molecules.

CAS Number

To be confirmed from certificate of analysis

Molecular Formula

C6H3ClN2S

Molecular Weight

170.62 g/mol

Key Reactive Site

C-4 chloride; susceptible to nucleophilic aromatic substitution (SNAr)

Recommended Storage

Cool, dry, dark conditions; sealed under inert atmosphere

Primary Applications

Medicinal chemistry intermediate; scaffold for kinase inhibitor libraries

Materials and Safety Precautions

Before beginning work with 4-chlorothieno[3,2-d]pyrimidine (Aladdin SKU: C174655), gather the following materials and observe all relevant safety precautions:

• Personal protective equipment (PPE): Lab coat, chemical-resistant gloves (nitrile recommended), and safety goggles must be worn at all times.
• Ventilation: All weighing and reaction steps should be performed inside a well-ventilated chemical fume hood to minimise inhalation exposure to fine powder or vapours.
• Solvents: Dimethyl sulfoxide (DMSO), N,N-dimethylformamide (DMF), tetrahydrofuran (THF), or dichloromethane (DCM) are suitable for dissolving this compound. Use anhydrous grades when moisture-sensitive reactions are planned.
• Inert atmosphere: Although the compound is a solid, handling under nitrogen or argon is recommended to prevent potential moisture uptake and maintain product integrity over time.
• Waste disposal: Halogenated organic waste must be segregated and disposed of in accordance with local institutional and regulatory guidelines.
• SDS: Consult the Safety Data Sheet provided with the product before use. Specific hazard classifications should be confirmed from the current SDS.

Stock Solution Preparation

Preparation of a stock solution is recommended for efficient and reproducible use of 4-chlorothieno[3,2-d]pyrimidine in downstream reactions or biological assays.

1. Determine target concentration: A stock concentration of 100 mM in DMSO is commonly used for screening applications, while 0.1–1.0 M solutions in DMF or THF are typical for synthetic chemistry purposes.
2. Calculate mass required: Using the molecular weight of 170.62 g/mol, calculate the mass of compound required. Example: for 1 mL of a 100 mM DMSO stock, weigh 17.06 mg of compound.
3. Dissolve the compound: Transfer the weighed compound to a clean, dry glass vial. Add approximately 80% of the target solvent volume, cap the vial, and vortex or gently sonicate until fully dissolved. Make up to final volume.
4. Quality check: Inspect visually for complete dissolution. If turbidity persists, warm gently (do not exceed 40 °C for DMSO stocks) and vortex again.
5. Aliquot and store: Divide the stock into single-use aliquots in sealed vials under inert gas. Store at –20 °C or as specified on the product label. Avoid repeated freeze-thaw cycles to maintain compound integrity.

Note: Solubility data specific to this compound should be confirmed from the certificate of analysis or empirically determined if not available.

Nucleophilic Aromatic Substitution (SNAr) Protocol

The C-4 chloride of 4-chlorothieno[3,2-d]pyrimidine is activated toward nucleophilic aromatic substitution (SNAr) due to the electron-withdrawing effect of the pyrimidine ring nitrogen atoms. The following general procedure may be adapted for amine nucleophiles:

1. Set up the reaction flask: Flame-dry or oven-dry a round-bottom flask equipped with a magnetic stir bar and a reflux condenser. Purge with nitrogen or argon.
2. Add reagents: Charge the flask with 4-chlorothieno[3,2-d]pyrimidine (1.0 equiv), the amine nucleophile (1.05–1.5 equiv), and a suitable base such as triethylamine or N,N-diisopropylethylamine (DIPEA, 2.0 equiv) in an appropriate solvent (e.g., isopropanol, DMF, or THF).
3. Heat and stir: Heat the reaction mixture to 60–100 °C (temperature is substrate-dependent) with stirring under inert atmosphere. Monitor reaction progress by TLC or LCMS.
4. Work-up: Upon completion, cool the reaction to room temperature. Dilute with ethyl acetate or DCM, wash with aqueous base (e.g., saturated NaHCO3), then brine. Dry the organic layer over anhydrous Na2SO4 or MgSO4, filter, and concentrate under reduced pressure.
5. Purification: Purify the crude product by silica gel column chromatography using an appropriate solvent gradient, or by recrystallisation if suitable conditions can be identified.
6. Characterisation: Confirm product identity and purity by 1H NMR, 13C NMR, and HRMS or LCMS.

Note: Specific reaction conditions (temperature, solvent, base, equivalents) should be optimised empirically for each nucleophile. The above represents a general starting point based on established SNAr methodology for activated chloropyrimidines.

Troubleshooting

The following table summarises common issues encountered when working with 4-chlorothieno[3,2-d]pyrimidine and recommended corrective actions:

Problem	Likely Cause	Recommended Action
Incomplete dissolution of stock	Insufficient solvent, low temperature, or incompatible solvent	Switch to DMSO or DMF; warm gently; increase solvent volume
Low conversion in SNAr reaction	Insufficient activation, low temperature, weak nucleophile	Increase temperature; switch to a stronger base; use polar aprotic solvent
Multiple by-products observed	Excess nucleophile or harsh conditions	Reduce equivalents of nucleophile; lower reaction temperature; monitor by TLC/LCMS
Product decomposition during work-up	Hydrolysis of thienopyrimidine or sensitive substituents	Minimise aqueous exposure time; use mild wash conditions; purify promptly
Poor column chromatography separation	Similar polarity of product and starting material	Optimise eluent system; consider reverse-phase HPLC for final purification

Quality Control and Storage Guidelines

Maintaining the quality of 4-chlorothieno[3,2-d]pyrimidine is essential for reproducible experimental outcomes. Adhere to the following guidelines:

• Acceptance testing: Upon receipt, verify the compound identity by comparing the 1H NMR spectrum with the certificate of analysis (CoA). Purity should be confirmed by HPLC or GC as specified on the CoA.
• Storage conditions: Store the neat compound in a tightly sealed container under inert atmosphere at cool and dry conditions. Refer to the product label for specific temperature requirements.
• Stability: Halogenated heteroaromatic compounds may be susceptible to slow hydrolysis or oxidation under prolonged ambient exposure. Minimise air and moisture contact.
• Re-testing: If the compound has been stored for an extended period, re-analyse by NMR or HPLC before use in critical experiments to confirm integrity.
• Lot-to-lot consistency: Record the lot number on all experimental data to enable traceability and facilitate comparison across experiments.

Frequently asked questions

What solvents are recommended for dissolving 4-chlorothieno[3,2-d]pyrimidine?

DMSO and DMF are the most commonly used solvents for this type of electron-deficient heteroaromatic compound and are recommended for biological screening stock solutions or synthetic applications respectively. THF and DCM are also suitable for synthetic use. Solubility should be confirmed empirically from the certificate of analysis if specific data are not provided.

How should 4-chlorothieno[3,2-d]pyrimidine be stored to maintain stability?

The compound should be stored in a tightly sealed container under an inert atmosphere (nitrogen or argon) in a cool, dry, and dark environment. Avoid repeated exposure to air and moisture. Consult the product label and certificate of analysis for specific temperature requirements, and re-test the compound by NMR or HPLC after extended storage.

What type of chemistry is 4-chlorothieno[3,2-d]pyrimidine typically used for?

This compound primarily serves as an electrophilic building block in nucleophilic aromatic substitution (SNAr) reactions, where the C-4 chloride is displaced by nitrogen, oxygen, or sulfur nucleophiles to generate diverse thienopyrimidine derivatives. It is widely used in medicinal chemistry for constructing kinase inhibitor scaffolds and other bioactive small molecule libraries.

Can 4-chlorothieno[3,2-d]pyrimidine be used in palladium-catalysed cross-coupling reactions?

In principle, aryl and heteroaryl chlorides can participate in palladium-catalysed cross-coupling reactions such as Suzuki-Miyaura, Buchwald-Hartwig, and Negishi couplings, although activated chloropyrimidines may require optimised ligand and catalyst systems. Specific conditions for 4-chlorothieno[3,2-d]pyrimidine should be established empirically or by reference to literature procedures for analogous substrates.

References

1. Aladdin Scientific. Product Certificate of Analysis: 4-Chlorothieno[3,2-d]pyrimidine, SKU C174655. Aladdin Scientific, Shanghai.
2. March, J. Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 4th ed. Wiley-Interscience, 1992. (General SNAr methodology for activated halopyrimidines.)
3. Taylor, E. C.; Rampal, J. B. Thienopyrimidines as scaffolds in medicinal chemistry. (General reference on thienopyrimidine chemistry — specific citation to be confirmed.)

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.